Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Nitrous oxide induced myeloneuropathy: a case report.
Managing MS: Trends, Issues, and Perspectives.
Letter to the Editor.
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Oral laquinimod for multiple sclerosis.
Pediatric Multiple Sclerosis.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
The Development and Maintenance of Paclitaxel-Induced Neuropathic Pain Requires Activation of the Sphingosine 1-Phosphate Receptor Subtype 1.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
Brain circuitry outside the synaptic cleft.
[A Patient with Acute Limbic Encephalitis Associated with Anti-Glutamate Receptor Antibodies and Subsequent Optic Neuritis].
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study.
[Biomarkers in multiple sclerosis].
[New treatment options in multiple sclerosis and their complications].
Molecular cloning of a human cannabinoid receptor which is also expressed in testis.
CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers.
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Pages
« first
‹ previous
…
190
191
192
193
194
195
196
197
198
…
next ›
last »